Please use this identifier to cite or link to this item:
https://wslhd.intersearch.com.au/wslhdjspui/handle/1/14471| Title: | What is new in the 2025 APASL guidelines for metabolic dysfunction-associated fatty liver disease? |
| Authors: | Pan, Ziyan;Ormeci, N.;Chen, J.;Ghazinian, H.;Payawal, D.;Eslam, Mohammed |
| WSLHD Author: | Pan, Ziyan;Eslam, Mohammed |
| Subjects: | Hepatology;Region;Mortality;Delivery of Health Care |
| Issue Date: | 2026 |
| Citation: | Hepatobiliary Surgery and Nutrition. 15(1):16, 2026 Feb |
| Abstract: | No abstract available |
| URI: | https://wslhd.intersearch.com.au/wslhdjspui/handle/1/14471 |
| DOI: | https://doi.org/10.21037/hbsn-2025-590 |
| Journal: | Hepatobiliary Surgery and Nutrition |
| Type: | Editorial |
| Department: | Gastroenterology & Hepatology |
| Facility: | Westmead |
| Affiliated Organisations: | Storr Liver Centre, Westmead Institute for Medical Research, Westmead Hospital and University of Sydney, Sydney, NSW, Australia Department of Internal Medicine, Istanbul Health and Technology University, Istanbul, Turkiye Hepatology Unit, Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China Gastroenterology and Hepatology Department, Yerevan Medical Scientific Center, Yerevan, Armenia Department of Internal Medicine, Fatima University Medical Center/Hepatology Committee, Cardinal Santos Medical Center, MetroManila, Philippines |
| Keywords: | Asian Pacific Association for the Study of the Liver guidelines (APASL guidelines) Metabolic dysfunction-associated fatty liver disease (MAFLD) fatty liver disease. |
| Appears in Collections: | WSLHD publications |
Files in This Item:
There are no files associated with this item.
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.